Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K173833Substantially Equivalent

CRP Vario

Sentinel CH SpA, Milano, IT / Traditional, Substantially Equivalent

K173833 is the FDA 510(k) clearance record for CRP Vario, a class II device, cleared for SENTINEL CH. SpA on under FDA product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control). FDA's definition for product code NQD reads: "In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments". FDA records list 22 510(k) clearances for SENTINEL CH. SpA, from to . As of , FDA records show no recalls naming K173833.

Clearance record

Decision date
Received
(283 days to decision)
Product code
NQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Regulation
21 CFR 866.5270
Device class
Class II
Review panel
Immunology
Applicant
SENTINEL CH. SpA Via Robert Koch, 2, Milano, IT
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NQD

Trailing 12 months
1 clearance under product code NQD in the twelve months to October 2026, April 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code NQD, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260